BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Li X, Yan F, Pan Q, Yang C, Wu M, Li G, Liu H. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway. International Immunopharmacology 2019;66:336-46. [DOI: 10.1016/j.intimp.2018.11.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang D, Li J, Liang C, Tian L, Shi C, Hui N, Liu Y, Ling M, Xin L, Wan M, Li H, Zhao Q, Ren X, Liu H, Cao W. Syringa microphylla Diels: A comprehensive review of its phytochemical, pharmacological, pharmacokinetic, and toxicological characteristics and an investigation into its potential health benefits. Phytomedicine 2021;93:153770. [PMID: 34678528 DOI: 10.1016/j.phymed.2021.153770] [Reference Citation Analysis]
2 Yu Y, Sun H, Zhu L, Ji L, Liu H. Downregulating lncRNA PRNCR1 ameliorates LPS-induced pulmonary vascular endothelial cell injury by modulating miR-330-5p/TLR4 axis. J Biochem Mol Toxicol 2021;35:e22644. [PMID: 33049095 DOI: 10.1002/jbt.22644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Peng LY, Yuan M, Shi HT, Li JH, Song K, Huang JN, Yi PF, Fu BD, Shen HQ. Protective Effect of Piceatannol Against Acute Lung Injury Through Protecting the Integrity of Air-Blood Barrier and Modulating the TLR4/NF-κB Signaling Pathway Activation. Front Pharmacol 2019;10:1613. [PMID: 32038265 DOI: 10.3389/fphar.2019.01613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Kim SM, Ryu HW, Kwon OK, Hwang D, Kim MG, Min JH, Zhang Z, Kim SY, Paik JH, Oh SR, Ahn KS, Lee JW. Callicarpa japonica Thunb. ameliorates allergic airway inflammation by suppressing NF-κB activation and upregulating HO-1 expression. J Ethnopharmacol 2021;267:113523. [PMID: 33129947 DOI: 10.1016/j.jep.2020.113523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fatima M, Slade H, Horwitz L, Shi A, Liu J, Mckinstry D, Villani T, Xu H, Duan B. Abnormal Somatosensory Behaviors Associated With a Gain-of-Function Mutation in TRPV3 Channels. Front Mol Neurosci 2022;14:790435. [DOI: 10.3389/fnmol.2021.790435] [Reference Citation Analysis]
6 Kong F, Jiang X, Wang R, Zhai S, Zhang Y, Wang D. Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease. J Neuroinflammation 2020;17:305. [PMID: 33059746 DOI: 10.1186/s12974-020-01967-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Luo J, Ma Q, Tang H, Zou X, Guo X, Hu Y, Zhou K, Liu R, Lajunen TK. LTB4 Promotes Acute Lung Injury via Upregulating the PLCε-1/TLR4/NF-κB Pathway in One-Lung Ventilation. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/1839341] [Reference Citation Analysis]
8 Fu S. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway. Int J Mol Med 2020;46:131-40. [PMID: 32626914 DOI: 10.3892/ijmm.2020.4599] [Reference Citation Analysis]
9 Kaya S, Albayrak Kaya S, Polat E, Fidanol Erboğa Z, Duran Y, Polat FR, Okuyan HM, Karaboğa İ. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury in a rat model. Turk Gogus Kalp Damar Cerrahisi Derg 2019;28:359-68. [PMID: 32551168 DOI: 10.5606/tgkdc.dergisi.2020.18816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liang H, Liu K, Zhuang Z, Sun H, Sun B, Jiao M, Cai Y, Cai G. Potential of Forsythoside I as a therapeutic approach for acute lung injury: Involvement of TXNIP/NLRP3 inflammasome. Mol Immunol 2021;134:192-201. [PMID: 33812251 DOI: 10.1016/j.molimm.2021.03.004] [Reference Citation Analysis]
11 Ding J, Liu Q. Toll-like receptor 4: A promising therapeutic target for pneumonia caused by Gram-negative bacteria. J Cell Mol Med 2019;23:5868-75. [PMID: 31350813 DOI: 10.1111/jcmm.14529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Bian M, Gong G, Lei P, Du H, Bai C, Wei C, Quan Z, Ma Q. Design, Synthesis, and In Vitro and In Vivo Biological Evaluation of Limonin Derivatives for Anti-Inflammation Therapy. J Agric Food Chem 2021;69:13487-99. [PMID: 34713702 DOI: 10.1021/acs.jafc.1c04989] [Reference Citation Analysis]
13 Amaral-Machado L, Oliveira WN, Rodrigues VM, Albuquerque NA, Alencar ÉN, Egito EST. Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients? Biomed Pharmacother 2021;134:111143. [PMID: 33360048 DOI: 10.1016/j.biopha.2020.111143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lu J, Zhang L, Cheng L, He S, Zhang Y, Yan J, Zhou J. Xijiao Dihuang decoction improves prognosis of sepsis via inhibition of aerobic glycolysis. Biomed Pharmacother 2020;129:110501. [PMID: 32768976 DOI: 10.1016/j.biopha.2020.110501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wang B, Wang J, Lu D, Qi N, Liu Q. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals. J Invest Surg 2021;34:284-96. [PMID: 31274341 DOI: 10.1080/08941939.2019.1634165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Gao H, Xiao D, Gao L, Li X. MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway. Int J Mol Med 2020;46:561-70. [PMID: 32468034 DOI: 10.3892/ijmm.2020.4610] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]